BLI Banque de Luxembourg Investments Sells 1,700 Shares of Mettler-Toledo International, Inc. $MTD

BLI Banque de Luxembourg Investments cut its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 21.3% during the fourth quarter, HoldingsChannel reports. The firm owned 6,300 shares of the medical instruments supplier’s stock after selling 1,700 shares during the period. BLI Banque de Luxembourg Investments’ holdings in Mettler-Toledo International were worth $8,915,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in MTD. Nordea Investment Management AB increased its stake in Mettler-Toledo International by 11.9% during the fourth quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock valued at $220,718,000 after acquiring an additional 16,777 shares during the period. Citigroup Inc. grew its stake in shares of Mettler-Toledo International by 4.8% in the 3rd quarter. Citigroup Inc. now owns 65,033 shares of the medical instruments supplier’s stock valued at $79,835,000 after purchasing an additional 2,989 shares during the period. Pensionfund Sabic bought a new stake in shares of Mettler-Toledo International in the 4th quarter valued at approximately $1,255,000. Illinois Municipal Retirement Fund grew its stake in shares of Mettler-Toledo International by 21.6% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 7,854 shares of the medical instruments supplier’s stock valued at $9,642,000 after purchasing an additional 1,393 shares during the period. Finally, M&T Bank Corp grew its stake in shares of Mettler-Toledo International by 2,813.6% in the 4th quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock valued at $173,165,000 after purchasing an additional 119,942 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,139.04 on Tuesday. The company has a market capitalization of $23.02 billion, a P/E ratio of 26.71, a PEG ratio of 2.41 and a beta of 1.27. Mettler-Toledo International, Inc. has a one year low of $1,023.05 and a one year high of $1,525.17. The business’s 50 day simple moving average is $1,212.95 and its 200-day simple moving average is $1,320.79.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, topping the consensus estimate of $8.70 by $0.21. The business had revenue of $947.13 million for the quarter, compared to the consensus estimate of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.Mettler-Toledo International’s revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

MTD has been the topic of several analyst reports. Wolfe Research initiated coverage on Mettler-Toledo International in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Citigroup lowered their price objective on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Stifel Nicolaus lowered their price objective on Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating on the stock in a research note on Monday, May 18th. Jefferies Financial Group upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating and upped their price objective for the company from $1,400.00 to $1,450.00 in a research note on Friday, March 20th. Finally, Robert W. Baird lowered their price objective on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and an average price target of $1,408.55.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.